“No cancer drug is safe, it’s always a trade-off,” says oncologist Bishal Gyawali, whose study found that many cancer drug studies downplay adverse events.
A new FDA approved test can determine how your body metabolizes medications. But is this and other pharmacogenomic testing really useful for consumers?
The FDA just approved a new drug that can shorten duration of the flu by about a day. Is it worth taking Xofluza and how does it compare to Tamiflu?
Last year, the FDA received more than 1.8 million reports of drug adverse events. Adverse drug reactions are a factor in over 100,000 deaths annually.
A study finds many supplements tainted with pharmaceutical drugs remain on the market amid a lack of appropriate FDA enforcement. What can be done to fix this?